Витамин D для Alopecia Areata

References

1. [1] Ahmed Abdulaziz Alsaati et al.. Indian Dermatol Online J. 2026. Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis. doi:10.4103/idoj.idoj_958_24 PubMed
2. [2] Erick Alejandro Jiménez-Herrera et al.. Skin Appendage Disord. 2025. Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications. doi:10.1159/000545711 PubMed
3. [3] Ruiying Wu et al.. J Cosmet Dermatol. 2025. Association Between Serum Trace Elements Level and Alopecia Areata: A Systematic Review and Meta-Analysis. doi:10.1111/jocd.16740 PubMed
4. [4] Farheen Begum et al.. Indian Dermatol Online J. 2025. Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with … doi:10.4103/idoj.idoj_913_23 PubMed
5. [5] Ghadah Alhetheli et al.. Clin Cosmet Investig Dermatol. 2025. Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata. doi:10.2147/CCID.S504475 PubMed
6. [6] Adam Leavitt et al.. J Drugs Dermatol. 2025. Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions. doi:10.36849/JDD.8763 PubMed
7. [7] Alberto Soto-Moreno et al.. Acta Dermatovenerol Croat. 2025. Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study. PubMed
8. [8] Rasha Moumna et al.. Cureus. 2025. Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata. doi:10.7759/cureus.84000 PubMed
9. [9] Yuling Chen et al.. J Cosmet Dermatol. 2024. Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis. doi:10.1111/jocd.16093 PubMed
10. [10] Irem Nur Durusu Turkoglu et al.. J Cosmet Dermatol. 2024. A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid … doi:10.1111/jocd.16512 PubMed
11. [11] Ahmed Ibrahim AbdElneam et al.. Skin Res Technol. 2024. C-reactive protein as a novel biomarker for vitamin D deficiency in alopecia areata. doi:10.1111/srt.13657 PubMed
12. [12] Tanat Yongpisarn et al.. Front Nutr. 2024. Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis. doi:10.3389/fnut.2024.1479337 PubMed
13. [13] Siddhi B Chikhalkar et al.. Indian Dermatol Online J. 2024. Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata. doi:10.4103/idoj.idoj_535_23 PubMed
14. [14] Maha H Ragaie et al.. J Cosmet Laser Ther. 2024. Intralesional vitamin D3 versus intralesional triamcinolone acetonoid in patchy alopecia areata: a comparative clinical and dermoscopic study. doi:10.1080/14764172.2024.2389275 PubMed
15. [15] Palwasha Jalil et al.. Dermatol Pract Concept. 2024. Filling the Gaps: Vitamin D Status in Diffuse Hair Fall Among Pakistanis. doi:10.5826/dpc.1404a232 PubMed
16. [16] Mohammed Ibrahim AlJasser. Clin Cosmet Investig Dermatol. 2024. Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients. doi:10.2147/CCID.S499794 PubMed
17. [17] Yuting Cao et al.. Skin Res Technol. 2024. Association of vitamin D with risk of warts: A retrospective and Mendelian randomization study. doi:10.1111/srt.13911 PubMed
18. [18] Sophia Ly et al.. Am J Clin Dermatol. 2023. Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis. doi:10.1007/s40257-023-00805-4 PubMed
19. [19] Hanane Touil et al.. Front Immunol. 2023. Differential impact of environmental factors on systemic and localized autoimmunity. doi:10.3389/fimmu.2023.1147447 PubMed
20. [20] Mohammed Saleh Al-Dhubaibi et al.. Skin Res Technol. 2023. Trichoscopy pattern in alopecia areata: A systematic review and meta-analysis. doi:10.1111/srt.13378 PubMed
21. [21] Hiba Zaaroura et al.. Autoimmun Rev. 2023. Biomarkers in alopecia Areata: A systematic review and meta-analysis. doi:10.1016/j.autrev.2023.103339 PubMed
22. [22] Amany Nassar et al.. J Cosmet Dermatol. 2023. Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol … doi:10.1111/jocd.15558 PubMed
23. [23] Yilan Zeng et al.. Mini Rev Med Chem. 2023. The Role of VD/VDR Signaling Pathway in Autoimmune Skin Diseases. doi:10.2174/1389557523666221124123206 PubMed
24. [24] Vivien Chen et al.. Pediatr Dermatol. 2023. Etiology, management, and outcomes of pediatric telogen effluvium: A single-center study in the United States. doi:10.1111/pde.15154 PubMed
25. [25] Mona S Ali et al.. J Cosmet Dermatol. 2023. Combined microneedling with topical vitamin D3 or bimatoprost versus microneedling alone in the treatment of alopecia areata: A comparative randomized … doi:10.1111/jocd.15569 PubMed
26. [26] Adel Alsenaid et al.. Photodiagnosis Photodyn Ther. 2023. Trichoscopy pattern and evaluation of serum vitamin D status in alopecia areata. doi:10.1016/j.pdpdt.2023.103510 PubMed
27. [27] Fatemeh Mokhtari et al.. J Cosmet Dermatol. 2023. Inverse correlation between vitamin D and CRP levels in alopecia areata: A pilot study. doi:10.1111/jocd.15994 PubMed
28. [28] N M Dawoud et al.. J Cosmet Dermatol. 2023. Serum brain-derived neurotrophic factor and vitamin D: Two concordant players controlling depression among alopecia areata and vitiligo patients: A case-control … doi:10.1111/jocd.15725 PubMed
29. [29] Marissa S Ceresnie et al.. Arch Dermatol Res. 2023. The development of non-scarring alopecia in women who wear the hijab. doi:10.1007/s00403-023-02713-3 PubMed
30. [30] Azza Mahfouz Abdel Meguid et al.. Arch Dermatol Res. 2023. Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and … doi:10.1007/s00403-023-02565-x PubMed
31. [31] Elham Hamidpour et al.. Health Sci Rep. 2023. Effects of age and sex on the comorbidities of alopecia areata: A cross-sectional hospital-based study. doi:10.1002/hsr2.1444 PubMed
32. [32] Manisha Singh Basukala et al.. J Nepal Health Res Counc. 2023. Determination of Serum 25-Hydroxyvitamin D Levels in Patients with Alopecia Areata. doi:10.33314/jnhrc.v20i3.4408 PubMed
33. [33] Amira Fathy Rashad et al.. J Cosmet Dermatol. 2022. Intralesional vitamin D3 in treatment of alopecia areata: A randomized controlled clinical trial. doi:10.1111/jocd.14844 PubMed
34. [34] Ahu Yorulmaz et al.. J Cosmet Dermatol. 2022. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. doi:10.1111/jocd.14413 PubMed
35. [35] Yamei Gao et al.. J Cosmet Dermatol. 2022. Evaluation of several immune and inflammatory indicators and their association with alopecia areata. doi:10.1111/jocd.14504 PubMed
36. [36] Ümran Öner et al.. Turk J Med Sci. 2022. Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom? doi:10.3906/sag-2106-28 PubMed
37. [37] Sule Goksin. North Clin Istanb. 2022. Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata. doi:10.14744/nci.2022.78790 PubMed
38. [38] Shawn Afvari et al.. J Am Acad Dermatol. 2022. Reply to "Vitamin D status in scarring and nonscarring alopecia". doi:10.1016/j.jaad.2022.04.055 PubMed
39. [39] Baohua Zhu et al.. Medicine (Baltimore). 2022. Vitamin D supplementation for patients with alopecia areata: A protocol for systematic review and meta-analysis. doi:10.1097/MD.0000000000031089 PubMed
40. [40] Patrick Thanh Tran et al.. Int J Trichology. 2022. Vitamin D Levels in Alopecia Areata and Other Alopecias: A Retrospective Case- Control Study at a Single Institution. doi:10.4103/ijt.ijt_131_20 PubMed
41. [41] Rachel K Lim et al.. Cureus. 2022. Predictors of Vitamin D Insufficiency in Children and Adolescents With Alopecia Areata. doi:10.7759/cureus.22934 PubMed
42. [42] Danchen Hu et al.. Am J Dermatopathol. 2022. Rare Concurrence of Alopecia Areata in the Setting of the Lipedematous Scalp. doi:10.1097/DAD.0000000000002261 PubMed
43. [43] Ginny Oong Chien Yin et al.. J Dermatol Sci. 2021. Telogen Effluvium - a review of the science and current obstacles. doi:10.1016/j.jdermsci.2021.01.007 PubMed
44. [44] Kriteeka Saini et al.. J Cosmet Dermatol. 2021. Role of vitamin D in hair loss: A short review. doi:10.1111/jocd.14421 PubMed
45. [45] Khaled Babaei et al.. An Bras Dermatol. 2021. Characteristics of telogen effluvium in COVID-19 in western Iran (2020). doi:10.1016/j.abd.2021.05.006 PubMed
46. [46] Zainab Zubair et al.. Cureus. 2021. Prevalence of Low Serum Vitamin D Levels in Patients Presenting With Androgenetic Alopecia: A Review. doi:10.7759/cureus.20431 PubMed
47. [47] Basak Yalici-Armagan et al.. Int J Clin Pract. 2021. Paediatric lichen sclerosus et atrophicus: A retrospective analysis of 38 paediatric patients. doi:10.1111/ijcp.14661 PubMed
48. [48] Farah Sattar et al.. J Nutr Sci Vitaminol (Tokyo). 2021. Efficacy of Oral Vitamin D3 Therapy in Patients Suffering from Diffuse Hair Loss (Telogen Effluvium). doi:10.3177/jnsv.67.68 PubMed
49. [49] Dimitrios T Papadimitriou et al.. World J Clin Pediatr. 2021. Treatment of alopecia totalis/universalis/focalis with vitamin D and analogs: Three case reports and a literature review. doi:10.5409/wjcp.v10.i6.192 PubMed
50. [50] Saeed M Alamoudi et al.. Cureus. 2021. Association Between Vitamin D and Zinc Levels With Alopecia Areata Phenotypes at a Tertiary Care Center. doi:10.7759/cureus.14738 PubMed
51. [51] Giovanna Borriello et al.. Int J Environ Res Public Health. 2021. Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients. doi:10.3390/ijerph18147338 PubMed
52. [52] Felix Paolo J Lizarondo et al.. JAAD Int. 2021. Determination of serum 25-hydroxyvitamin D levels in patients with alopecia areata and their comparison with levels in healthy controls: A … doi:10.1016/j.jdin.2021.07.008 PubMed
53. [53] Enkhjargal Losol et al.. Dermatol Ther. 2021. Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation. doi:10.1111/dth.14726 PubMed
54. [54] R Z Conic et al.. J Eur Acad Dermatol Venereol. 2020. Comorbidities in pediatric alopecia areata. doi:10.1111/jdv.16727 PubMed
55. [55] Elisa Molinelli et al.. Dermatol Ther (Heidelb). 2020. Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot … doi:10.1007/s13555-020-00379-7 PubMed
56. [56] Sarita Sanke et al.. Int J Dermatol. 2020. Study of serum vitamin D levels in men with premature androgenetic alopecia. doi:10.1111/ijd.14982 PubMed
57. [57] Jun Zhao et al.. J Cosmet Dermatol. 2020. Serum 25 hydroxyvitamin D levels in alopecia areata, female pattern hair loss, and male androgenetic alopecia in a Chinese population. doi:10.1111/jocd.13396 PubMed
58. [58] Yi Liu et al.. Dermatol Ther (Heidelb). 2020. Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic Review and Meta-analysis. doi:10.1007/s13555-020-00433-4 PubMed
59. [59] Erika Titus-Lay et al.. Ment Health Clin. 2020. Trichotillomania associated with a 25-hydroxy vitamin D deficiency: A case report. doi:10.9740/mhc.2020.01.038 PubMed
60. [60] Cliff J Harvey. Cureus. 2020. Combined Diet and Supplementation Therapy Resolves Alopecia Areata in a Paediatric Patient: A Case Study. doi:10.7759/cureus.11371 PubMed
61. [61] Solam Lee et al.. J Am Acad Dermatol. 2019. Comorbidities in alopecia areata: A systematic review and meta-analysis. doi:10.1016/j.jaad.2018.07.013 PubMed
62. [62] Xiran Lin et al.. Am J Transl Res. 2019. Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy. PubMed
63. [63] F J Navarro-Triviño et al.. Actas Dermosifiliogr (Engl Ed). 2019. Vitamin D and the Skin: A Review for Dermatologists. doi:10.1016/j.ad.2018.08.006 PubMed
64. [64] Fozia Rehman et al.. Int J Trichology. 2019. Serum Vitamin D Levels and Alopecia Areata- A Hospital Based Case-Control Study from North-India. doi:10.4103/ijt.ijt_3_19 PubMed
65. [65] Moustafa A El Taieb et al.. Arch Dermatol Res. 2019. Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial. doi:10.1007/s00403-019-01943-8 PubMed
66. [66] Kavita Poonia et al.. J Cosmet Dermatol. 2019. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. doi:10.1111/jocd.12559 PubMed
67. [67] Harsha Siddappa et al.. Indian Dermatol Online J. 2019. Evaluation of Association of Vitamin D in Alopecia Areata: A Case-control Study of 100 Patients in a Tertiary Rural Hospital … doi:10.4103/idoj.IDOJ_84_18 PubMed
68. [68] Mahtab Alam et al.. Int J Trichology. 2019. Comparative Study of Efficacy of Topical Mometasone with Calcipotriol versus Mometasone Alone in the Treatment of Alopecia Areata. doi:10.4103/ijt.ijt_18_19 PubMed
69. [69] Suchana Marahatta et al.. J Nepal Health Res Counc. 2019. Study on Serum Vitamin D in Alopecia Areata Patients. doi:10.33314/jnhrc.1475 PubMed
70. [70] Hans-Klaus Goischke. Ther Clin Risk Manag. 2019. Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis. doi:10.2147/TCRM.S188941 PubMed
71. [71] Elio Kechichian et al.. Am J Clin Dermatol. 2018. Vitamin D and the Skin: An Update for Dermatologists. doi:10.1007/s40257-017-0323-8 PubMed
72. [72] S Lee et al.. J Eur Acad Dermatol Venereol. 2018. Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta-analysis. doi:10.1111/jdv.14987 PubMed
73. [73] Venkata Krishna Vamsi Gade et al.. Clin Exp Med. 2018. An investigation of vitamin D status in alopecia areata. doi:10.1007/s10238-018-0511-8 PubMed
74. [74] Manju Daroach et al.. Int J Dermatol. 2018. Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm. doi:10.1111/ijd.13851 PubMed
75. [75] Mehmet Unal et al.. J Cosmet Dermatol. 2018. Serum vitamin D level is related to disease severity in pediatric alopecia areata. doi:10.1111/jocd.12352 PubMed
76. [76] Tsung-Yu Tsai et al.. J Am Acad Dermatol. 2018. Vitamin D deficiency in patients with alopecia areata: A systematic review and meta-analysis. doi:10.1016/j.jaad.2017.07.051 PubMed
77. [77] Chun-An Yao. J Am Acad Dermatol. 2018. Serum vitamin D level and disease severity of alopecia areata: A meta-regression analysis. doi:10.1016/j.jaad.2018.05.009 PubMed
78. [78] Elana Putterman et al.. J Am Acad Dermatol. 2018. Response to "Vitamin D deficiency in patients with alopecia areata: A systematic review and meta-analysis" and an investigation of vitamin … doi:10.1016/j.jaad.2018.03.057 PubMed
79. [79] Yasmeen Jabeen Bhat et al.. Indian J Dermatol. 2018. Authors' Reply to Critical Comment on "Vitamin D Level in Alopecia Areata". doi:10.4103/ijd.IJD_15_18 PubMed
80. [80] Tsung-Yu Tsai et al.. J Am Acad Dermatol. 2018. Reply to: "Serum vitamin D level and disease severity of alopecia areata: A meta-regression analysis". doi:10.1016/j.jaad.2018.03.058 PubMed
81. [81] Radha Saini et al.. Indian J Dermatol. 2018. Critical Comment on "Vitamin D Level in Alopecia Areata". doi:10.4103/ijd.IJD_552_17 PubMed
82. [82] Jordan M Thompson et al.. Am J Clin Dermatol. 2017. The Role of Micronutrients in Alopecia Areata: A Review. doi:10.1007/s40257-017-0285-x PubMed
83. [83] Agnieszka Gerkowicz et al.. Int J Mol Sci. 2017. The Role of Vitamin D in Non-Scarring Alopecia. doi:10.3390/ijms18122653 PubMed
84. [84] Tarun Narang et al.. Dermatol Ther. 2017. Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study. doi:10.1111/dth.12464 PubMed
85. [85] Yasmeen Jabeen Bhat et al.. Indian J Dermatol. 2017. Vitamin D Level in Alopecia Areata. doi:10.4103/ijd.IJD_677_16 PubMed
86. [86] Seval Erpolat et al.. Postepy Dermatol Alergol. 2017. 25-hydroxyvitamin D status in patients with alopecia areata. doi:10.5114/ada.2017.67847 PubMed
87. [87] Rabia Ghafoor et al.. J Coll Physicians Surg Pak. 2017. Vitamin D Deficiency in Alopecia Areata. PubMed
88. [88] Zuhair Siddiqui et al.. Skinmed. 2017. Vitamin D Deficiency in an Alopecia Referral Clinic During a 3-Month Period: The Need to Pursue Systemic Screening. PubMed
89. [89] Ebru Karagün et al.. Postepy Dermatol Alergol. 2016. The role of serum vitamin D levels in vitiligo. doi:10.5114/pdia.2016.59507 PubMed
90. [90] Ola Ahmed Bakry et al.. Indian Dermatol Online J. 2016. Serum Vitamin D in patients with alopecia areata. doi:10.4103/2229-5178.190504 PubMed
91. [91] Marwa M T Fawzi et al.. J Cosmet Dermatol. 2016. Assessment of vitamin D receptors in alopecia areata and androgenetic alopecia. doi:10.1111/jocd.12224 PubMed
92. [92] Jordan M Thompson et al.. Arch Dermatol Res. 2016. Estimated serum vitamin D status, vitamin D intake, and risk of incident alopecia areata among US women. doi:10.1007/s00403-016-1687-y PubMed
93. [93] Meagen McCusker et al.. Clin Dermatol. 2016. Nutrition and skin: Kids are not just little people. doi:10.1016/j.clindermatol.2016.07.004 PubMed
94. [94] Aslı Aksu Çerman et al.. J Drugs Dermatol. 2015. Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study. PubMed
95. [95] Maria K Hordinsky. J Investig Dermatol Symp Proc. 2015. Current Treatments for Alopecia Areata. doi:10.1038/jidsymp.2015.41 PubMed
96. [96] Mahmud Mahamid et al.. Isr Med Assoc J. 2014. Association between vitamin D levels and alopecia areata. PubMed
97. [97] A Aksu Cerman et al.. Br J Dermatol. 2014. Vitamin D deficiency in alopecia areata. doi:10.1111/bjd.12980 PubMed
98. [98] Leyre Falto-Aizpurua et al.. Expert Opin Emerg Drugs. 2014. Emerging treatments in alopecia. doi:10.1517/14728214.2014.974550 PubMed
99. [99] Heidi Wat et al.. J Cutan Med Surg. 2014. Off-label uses of topical vitamin D in dermatology: a systematic review. doi:10.2310/7750.2013.13109 PubMed
100. [100] Y Y Lim et al.. Clin Exp Dermatol. 2014. Potential relationship between the canonical Wnt signalling pathway and expression of the vitamin D receptor in alopecia. doi:10.1111/ced.12241 PubMed
101. [101] Roberto d'Ovidio et al.. Dermatoendocrinol. 2013. Reduced level of 25-hydroxyvitamin D in chronic/relapsing Alopecia Areata. doi:10.4161/derm.24411 PubMed
102. [102] Phillip D Holler et al.. J Invest Dermatol. 2013. Retinoids putting the "a" in alopecia. doi:10.1038/jid.2012.441 PubMed
103. [103] H M Kim et al.. Clin Exp Dermatol. 2013. Inhibitory effect of tianeptine on catagen induction in alopecia areata-like lesions induced by ultrasonic wave stress in mice. doi:10.1111/ced.12047 PubMed
104. [104] Aman Samrao et al.. J Drugs Dermatol. 2013. Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroids. PubMed
105. [105] Dong Ha Kim et al.. Ann Dermatol. 2012. Successful treatment of alopecia areata with topical calcipotriol. doi:10.5021/ad.2012.24.3.341 PubMed
106. [106] Michael P Pender. Autoimmune Dis. 2012. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. doi:10.1155/2012/189096 PubMed
107. [107] Yousef Shafeghati et al.. Arch Iran Med. 2008. Vitamin D-dependent rickets type II: report of a novel mutation in the vitamin D receptor gene. PubMed
108. [108] Ahmet Akar et al.. Int J Dermatol. 2007. Vitamin D receptor gene polymorphisms are not associated with alopecia areata. doi:10.1111/j.1365-4632.2007.03140.x PubMed
109. [109] Ahmet Akar et al.. Eur J Dermatol. 2004. Lack of association between Vitamin D receptor FokI polymorphism and alopecia areata. PubMed
110. [110] W SCHUCHARD. Dtsch Med Wochenschr. 1955. [The treatment of alopecia areata and of dyshidrotic eczema with milk protein bound vitamin D 2]. doi:10.1055/s-0028-1116437 PubMed